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Abstract  19 
Purpose: Breaking prolonged sitting reduces postprandial glucose and insulin concentrations and 20 
influences skeletal muscle molecular signalling pathways but it is unknown whether breaking sitting 21 
also affects adipose tissue. Methods: Eleven central overweight participants (7 men and 4 post-22 
menopausal women) aged 50 ± 5 years (means ± SD) completed two mixed-meal feeding trials 23 
(PROLONGED SITTING versus BREAKING SITTING) in a randomised, counterbalanced design. 24 
The BREAKING SITTING intervention comprised walking for 2 min every 20 min over 5.5 h. Blood 25 
samples were taken at regular intervals to examine metabolic biomarkers and adipokine 26 
concentrations. Adipose tissue samples were taken at baseline and at 5.5 h to examine changes in 27 
mRNA expression and secretion of selected adipokines ex-vivo. Results: Postprandial glycaemia and 28 
insulinaemia were attenuated by approximately 50% and 40% in BREAKING SITTING compared 29 
to PROLONGED SITTING (iAUC: 359 ± 117 versus 697 ± 218 mmol·330 min·L-1, p = 0.001 and 30 
202 ± 71 versus 346 ± 150 nmol·330 min·L-1, p = 0.001, respectively). Despite these pronounced and 31 
sustained differences in postprandial glucose and insulin concentrations, adipose tissue mRNA 32 
expression for various genes (IL-6, leptin, adiponectin, PDK4, IRS1/2, PI3K and Akt1, etc.) and ex-33 
vivo adipose tissue secretion of IL-6, leptin and adiponectin were not different between trials. 34 
Conclusions: This study demonstrates that breaking sitting with short bouts of physical activity has 35 
very pronounced effects on systemic postprandial glucose and insulin concentrations but this does 36 
not translate into corresponding effects within adipose tissue.  37 
 38 
Key words: Sedentary, physical activity, gene expression, postprandial, insulin signalling     39 
 40 
  41 
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INTRODUCTION 42 
Adipose tissue is a sizeable and complex endocrine organ that plays a role in metabolic control in 43 
part through the secretion of adipokines such as adiponectin and Interleukin-6 (IL-6) (1). Adipose 44 
dysfunction is characterised by tissue-specific insulin resistance, local inflammation, fibrosis, and the 45 
abnormal secretion of adipokines (2). These adipokines regulate various physiological processes and 46 
play a crucial role in the pathophysiology of chronic diseases such as cardiovascular diseases and 47 
type 2 diabetes (1). Thus, there is a clear need to develop interventions and strategies that successfully 48 
target adipose tissue function.   49 
 50 
Regular prolonged exercise improves various aspects of adipose tissue function, including measures 51 
of inflammation and insulin sensitivity (3). This form of prolonged physical activity also has 52 
demonstrably important effects on various health outcomes including risk factors for cardiovascular 53 
disease and diabetes (4). Unfortunately, many people struggle to undertake such structured exercise 54 
and alternative forms of physical activity could potentially play an important role. In many modern 55 
societies, people spend much of their time engaged in sedentary behaviours such as using a computer 56 
and watching television. In addition to causing a positive energy balance and weight gain, several 57 
studies have shown that sedentary behaviour is associated with increased risk of abnormal glucose 58 
metabolism, metabolic syndrome, type 2 diabetes and cardiovascular disease (5). Thus, targeting this 59 
sedentary behaviour may be important for health. 60 
 61 
In support of this suggestion, short bouts of physical activity lasting just a few minutes spread over 62 
the course of a day improve postprandial triglyceridaemia, glycaemia and insulinaemia (6-9). 63 
Breaking prolonged sitting with short bouts of physical activity also affects skeletal muscle signalling 64 
pathways related to carbohydrate metabolism (8). However, there has been no assessment of whether 65 
breaking prolonged sedentary behaviour impacts upon adipose tissue physiology. If this strategy is 66 
effective, it would have major implications for the prevention and management of disorders 67 
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associated with dysfunctional adipose tissue. Thus, this study aims to examine the acute effect of 68 
breaking prolonged sedentary behaviour (sitting) on adipose tissue.   69 
 70 
MATERIALS AND METHODS 71 
Experimental design  72 
Eleven participants (7 men and 4 post-menopausal women) aged between 35 and 64 years with 73 
increased central adiposity were recruited via local advertisement. An initial screening was followed 74 
by two subsequent main trials (PROLONGED SITTING and BREAKING SITTING). Trials were 75 
conducted in a randomised, counterbalanced design separated by a 3–4 week wash-out period. Two 76 
identical meals based on participants’ total body mass were provided on the main trial days (morning 77 
and lunchtime).  Blood was taken regularly during the course of each trial and adipose tissue biopsies 78 
were taken at baseline and at the end of each trial. The study protocol was approved by Bristol 79 
Research Ethics Committee (REC reference number: 13/SW/0321) and is registered at 80 
ClinicalTrials.gov (ID: NCT02870088). All participants provided written informed consent before 81 
taking part.  82 
 83 
Power calculations 84 
There are no data regarding the effect of breaking prolonged sitting on adipose tissue. Adipose tissue 85 
is highly responsive to insulin (10) and we have therefore determined sample size based on 86 
differences in insulin responses to a standard meal. A previous similar study reported breaking 87 
prolonged sitting to reduce postprandial insulinaemia from 3337 IU·9 h·L-1 to 2470 IU·9 h·L-1 (9). 88 
Based on an estimated SD of 600 IU·9 h·L-1, we would require 9 participants to show a difference in 89 
iAUC for insulin with 95% power and 5% alpha using a 2-tailed paired t-test. Eleven participants 90 
were recruited to allow for drop out. 91 
 92 
 93 
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Inclusion and exclusion criteria 94 
Participants were required to be central overweight with at least a waist circumference of 80 cm for 95 
women and 94 cm for men (11) and weight stable (no self-reported change in weight ± 3%) (12) for 96 
at least 3 months prior to taking part in this study. Participants completed a health questionnaire to 97 
exclude any existing cardiovascular and metabolic diseases and a Physical Activity Readiness 98 
Questionnaire (PAR-Q) to ensure that participants were able to walk on the treadmill safely. 99 
Participants were asked to walk on a treadmill for 2 min to ensure that this would be tolerated. 100 
Smokers, pre-menopausal women and volunteers who used any medications which could influence 101 
metabolic and inflammatory responses were excluded. A summary of participants’ physical 102 
characteristics is shown in Table 1. 103 
 104 
[INSERT TABLE 1 ABOUT HERE] 105 
 106 
Pre-trial assessments   107 
Physical activity assessment  108 
As part of the pre-trial assessments, participants wore a combined heart rate/accelerometer monitor 109 
for 7 days to assess habitual physical activity energy expenditure (Actiheart, Cambridge 110 
Neurotechnology Ltd., Cambridge, UK). This was attached to the left of the chest via 2 adhesive ECG 111 
pads for 24 h per day except for during showering/bathing/swimming (13). 112 
 113 
Body composition analysis 114 
Body mass was assessed using digital scales post-void (TANITA corp., Tokyo, Japan). Waist and hip 115 
circumferences were assessed based on World Health Organisation guidelines (11). Body 116 
composition was determined by using Dual Energy X-ray Absorptiometry (DEXA; Discovery, 117 
Hologic, Bedford, UK). Abdominal subcutaneous and visceral adipose tissue mass was estimated 118 
from a central region between L1-L4 (14). 119 
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 120 
Trial days 121 
In the 72 h prior to each main trial, participants were asked to refrain from performing any vigorous-122 
intensity exercise. In the 48 h prior to each main trial, consuming alcohol/caffeine was not allowed 123 
and a weighed food and fluid record was completed. Participants were asked to replicate this diet 124 
prior to their second main trial. In addition, in the 48 h prior to each main trial, participants were 125 
asked to wear a pedometer (Yamax, Japan) to restrict their step counts to under 4,000 steps per day 126 
in order to mimic a sedentary lifestyle (15) and eliminate any acute effects from recent physical 127 
activity.  128 
 129 
A 12 h fast was performed before arriving at the laboratory on main trial days between 08:00–09:00 130 
am. After anthropometric measurements, participants rested on a bed for 15 min, followed by two 5 131 
min expired gas sample collections using Douglas bags (Hans Rudolph, MO, USA) to determine 132 
resting metabolic rate (RMR) (16) from substrate oxidation as described (17). 133 
 134 
After RMR assessment, a 20-gauge cannula (BD, VenflonTM Pro) was inserted into an antecubital 135 
forearm vein and a 10-ml baseline venous blood sample was taken and allocated into tubes with either 136 
EDTA or serum separation beads (Sarstedt Ltd, Leicester, UK). Plasma samples were centrifuged 137 
immediately at 3,465 g at 4°C for 10 min. Serum samples were left for 45 min to clot before 138 
centrifugation. Subcutaneous adipose tissue samples (~1 g) were subsequently taken under local 139 
anaesthetic (1 % lidocaine) from the area around the waist approximately 5 cm lateral to the umbilicus 140 
with a 14 G needle using an aspiration technique (18) followed by adipose tissue cleaning and 141 
processing as previously described (19). 142 
 143 
Two identical meals (breakfast and lunch) were provided and consumed within a 15-min period during 144 
each main trial. The first meal (breakfast) was consumed after taking the baseline adipose and blood 145 
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sample. The second meal (lunch) was consumed 3 h after the first. The test meal was prescribed 146 
according to total body mass and provided 0.35 g fat, 1.17 g carbohydrate, 0.29 g protein and 37 kJ 147 
energy per kilogram body mass (6). The percentage of energy from macronutrients was 35 % fat, 52 148 
% carbohydrate and 13 % protein (6). The meal comprised white bread (Hovis; soft white bread, 149 
medium sliced), sliced cheese (Sainsbury; cheese slices, basic), butter (Unilever; I can’t believe its 150 
not butter), mayonnaise (Hellmann; light mayonnaise), lettuce (Sainsbury; Iceberg lettuce), tomato 151 
(Sainsbury; tomatoes, basics), ham (Sainsbury; British honey roast), whole milk (Sainsbury; British), 152 
cocoa powder (Nesquik; cocoa powder), and yoghurt (Müller; fruit corner strawberry). 153 
 154 
Prolonged sitting and breaking prolonged sitting  155 
The study protocol is shown in Figure 1. In the PROLONGED SITTING trial, participants sat on a 156 
chair for the whole period. In the BREAKING SITTING trial, after consuming the first meal, 157 
participants walked 2 min on a treadmill at 6.4 km·h-1 speed (7) every 20 min for the following 180 158 
min. After finishing the second meal, participants continued 2 min of breaking prolonged sitting 159 
physical activity at the same speed every 20 min for the following 120 min. For the remainder of the 160 
time participants sat on a chair. Thus, in total, participants performed 15 two min bouts of walking 161 
throughout the trial (i.e., 30 min of physical activity over 300 min).  162 
 163 
Ratings of perceived exertion (RPE) and heart rate were collected in the last 30 seconds of each 2-164 
min bout of walking during the breaking sitting trial. Two, 1-min expired air samples were collected 165 
during the last minute of walking during the breaking sitting trial to estimate energy expenditure and 166 
substrate utilization. In addition, expired air samples were taken using Douglas bags (Hans Rudolph, 167 
MO, USA) during two 5-min periods of sitting to calculate total energy expenditure under resting 168 
conditions. While sitting, participants were only allowed to read, use a laptop or watch television but 169 
were otherwise asked to keep as still as possible throughout (including specific instructions to avoid 170 
fidgeting). In the first trial, participants were allowed to consume water ad libitum and the volume 171 
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ingested was replicated for the second trial. In each main trial, baseline blood samples were collected 172 
before the first meal and hourly for the following 5 h. Additional blood samples were collected every 173 
15 min for the first hour after each meal. A total of 14 blood samples were collected for each trial 174 
(Figure 1).  175 
 176 
[INSERT FIGURE 1 ABOUT HERE] 177 
 178 
Adipose tissue culture and gene expression  179 
After cleaning and mincing the adipose tissue biopsy sample, a 200 mg portion of adipose tissue was 180 
homogenised in 5 mL TRIzol (Invitrogen, Paisley, UK) in a 15 mL centrifuge RNase/DNase-free 181 
sterile tube (Invitrogen, Paisley, UK) and stored at −80°C for gene expression analysis. The remaining 182 
adipose tissue was directly placed in sterile culture plates in duplicate (Nunc, Roskilde, Denmark) 183 
with endothelial cell basal media (ECBM) (Promocell, Germany) containing 0.1 % fatty acid-free 184 
bovine serum albumin 100 U·mL-1 penicillin and 0.1 mg·mL-1 streptomycin (Sigma-Aldrich, 185 
Gillingham, UK). Adipose tissue was incubated with a final ratio of 100 mg tissue per 1 mL ECBM 186 
media for 3 h (19). A 37°C, 5 % CO2 and 95 ± 5 % relative humidity incubator was used (MCO-187 
18A1C CO2 incubator; Sanyo, Osaka, Japan). After the 3-h incubation, media was transferred to 188 
sterile eppendorfs and stored at −80°C. Adipokine secretion from cultured adipose explants was 189 
normalised to explant adipose mass and then L1-L4 fat mass as described previously (20).  190 
 191 
Real-time PCR 192 
An RNeasy Mini Kit (Qiagen, Crawley, UK) was used to extract RNA from TRIzol-digested adipose 193 
tissue as described (18). The amount of RNA was quantified using a Qubit 2.0 fluorimeter (Life 194 
Technologies, Paisley, UK). RNA was reversed transcribed (1 μg) to cDNA using a High Capacity 195 
Reverse Transcription Kit (Applied Biosystems, Warrington, UK). Real-time PCR was performed 196 
using a StepOne (Applied Biosystems, Warrington, UK). Predesigned primers and probes were 197 
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obtained from Applied Biosystems for the measurement of expression of interleukin 6 (IL-6) 198 
(Hs00985639_m1), adiponectin (Hs00605917_m1), leptin (Hs00174877_m1), interleukin 18 (IL-18) 199 
(Hs00155517_m1), tumour necrosis factor alpha  (TNF-α) (Hs99999043_m1), monocyte 200 
chemoattractant protein-1 (MCP-1) (Hs00234140_m1), 5’ AMP-activated protein kinase (AMPK) 201 
(Hs01562315_m1 and Hs00178903_m1 combined), glucose transporter type 4 (GLUT4) 202 
(Hs00168966_m1), hormone-sensitive lipase (HSL) (Hs00193510_m1), insulin receptor substrate 1 203 
(IRS1) (Hs00178563_m1), insulin receptor substrate 2 (IRS2) (Hs00275843_s1), sterol regulatory 204 
element binding protein 1c (SREBP-1c) (Hs01088691_m1), pyruvate dehydrogenase kinase isozyme 205 
(PDK4) (Hs00176875_m1), peroxisome proliferator-activated receptor γ (PPARγ) 206 
(Hs01115513_m1), peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) 207 
(Hs01016719_m1), RAC-alpha serine/threonine-protein kinase (Akt1) (Hs00178289_m1), adipose 208 
triglyceride lipase (ATGL) (Hs00386101_m1), fatty acid translocase (FAT)/CD36 209 
(Hs00169627_m1), forkhead box protein O1 (FOXO1) (Hs01054576_m1), hexokinase 2 (HK2) 210 
(Hs00606086_m1), phosphoinositide 3-kinase 85α (PI3K-85α) (Hs00933163_m1), fatty acid 211 
synthase (FAS) (Hs00188012_m1), peptidylpropyl isomerase A (PPIA) was used as an endogenous 212 
control (21). The comparative Ct method was used to process data where ΔCt = Ct target gene − Ct 213 
PPIA. Ct target genes were normalised to an internal calibrator (lowest ΔCt for each target gene) and 214 
baseline. 215 
 216 
Biochemical analyses  217 
Concentrations of plasma glucose, plasma triglycerides and serum non-esterified fatty acids were 218 
analysed using commercially available assay kits and analyser (Daytona Rx; Randox, Crumlin, UK). 219 
Serum insulin (Mercodia, Uppsala, Sweden), and both serum and adipose explant secretion of IL-6, 220 
leptin, and adiponectin (R&D systems) were measured using Enzyme-linked immunosorbent assay 221 
(ELISA). 222 
 223 
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Statistical analysis  224 
Descriptive data are presented in text and tables as means ± standard deviation (SD); variance bars 225 
on figures are presented as means and standard error of the mean (SEM). Time series data were 226 
examined using a two-way ANOVA (trial × time) with repeated measures using SPSS version 22 227 
(IBM, Armonk, NY, USA). Green-house–Geisser corrections were applied to intra-individual 228 
contrasts where ε < 0.75; however, for less severe asphericity the Huynh–Feldt correction was 229 
selected (22) . Incremental area under curve (iAUC) was calculated using the trapezoid method (23) 230 
and the differences in summative scores between trials were analysed using paired t-tests.  Data for 231 
iAUC represent the period from the consumption of the first meal to the conclusion of the second 232 
meal (330 min). Analysis of iAUCs and gene expression data were conducted using logged 233 
transformed data as previously described (18). Statistical significance was set at p ≤ 0.05.  234 
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RESULTS 235 
Blood glucose, insulin, triglyceride and NEFA concentrations in prolonged and breaking sitting 236 
trials 237 
Trial × Time interaction effects were found for blood glucose and insulin between PROLONGED 238 
and BREAKING SITTING trials (all p ≤ 0.05, Figure 2A and C). The glucose and insulin iAUC were 239 
attenuated significantly by BREAKING SITTING compared to PROLONGED SITTING (359 ± 117 240 
versus 697 ± 218 mmol·330 min·L-1, p = 0.001 and 202 ± 71 versus 346 ± 150 nmol·330 min·L-1, p 241 
= 0.001, respectively, Figure 2B and D). There was no interaction effect for blood triglyceride and 242 
NEFA (Figure 2E and G). Triglyceride iAUC was significantly higher in BREAKING SITTING 243 
compared to PROLONGED SITTING trial (283 ± 36 vs. 232 ± 32 mmol·330 min·L-1, p = 0.002, 244 
respectively, Figure 2F). 245 
 246 
  [INSERT FIGURE 2 ABOUT HERE] 247 
 248 
Adipose tissue mRNA gene expression 249 
There was no interaction effect (trial × time) in adipose tissue mRNA gene expression between 250 
BREAKING SITTING and PROLONGED SITTING trials for any of the genes analysed (Figure 3). 251 
However, there were time effects for IL-6, MCP1, PDK4, IRS1 and 2, PI3K, HSL and SREBP1c (all 252 
p ≤ 0.05, Figure 3). 253 
 254 
[INSERT FIGURE 3 ABOUT HERE] 255 
 256 
 257 
12 
 
Serum adipokine concentrations and adipose tissue adipokine secretion ex vivo  258 
There was no difference between PROLONGED SITTING and BREAKING SITTING in serum IL-259 
6, leptin and adiponectin (Figure 4A, C and E) or the secretion ex vivo of IL-6, leptin and adiponectin 260 
(Figure 4B, D and F). There was a time effect for serum IL-6 and leptin (p ≤ 0.05) (Figure 4). 261 
      262 
      [INSERT FIGURE 4 ABOUT HERE] 263 
 264 
Pre-trial physical activity and resting metabolic rate measures 265 
The average of 48 h step counts prior to PROLONGED and BREAKING SITTING trials was not 266 
different (3,868 ± 1,304 versus 3,669 ± 1,090 steps·day-1, respectively) and there was no difference 267 
in pre-fed RMR on the trial day between trials (1,882 ± 303 versus 1,833 ± 338 kcal·day-1, 268 
respectively). 269 
 270 
Physiological response during trials 271 
During the 15 bouts of two min walking, the average heart rate was 135 ± 12 beats· min-1 with an 272 
RPE (6–20 scale) of 10 ± 2. The difference in energy expenditure between trials was 216 kcal over 273 
the 5.5 h period (Table 2). 274 
 275 
[INSERT TABLE 2 ABOUT HERE] 276 
  277 
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DISCUSSION 278 
The present study investigated whether breaking sitting with regular short bouts of walking influences 279 
adipose tissue gene expression and secretion of selected proteins from adipose tissue ex vivo. We 280 
found that regularly participating in short bouts of walking reduced postprandial glycaemic and 281 
insulinaemic responses by 48% and 42%, respectively. However, despite the profound difference in 282 
postprandial insulin and glucose concentrations, changes in subcutaneous adipose gene expression 283 
were similar in both trials. There was also no difference in adipose tissue explant secretion and 284 
circulating concentrations of IL-6, adiponectin or leptin. 285 
 286 
The effect of breaking sitting on postprandial glycaemia and insulinaemia  287 
The extent of postprandial glucose and insulin excursions are associated with cardiovascular disease 288 
(24, 25). Therefore, strategies to attenuate postprandial glucose and insulin responses would be 289 
extremely useful. Breaking prolonged sitting has been shown to reduce postprandial glucose and 290 
insulin levels in most (7, 9, 26) but not all studies (27). In the present study, we found that 291 
participating in regular short bouts of walking attenuated postprandial glucose and insulin 292 
concentrations in sedentary middle-aged central overweight men and women (glucose and insulin 293 
iAUC’s were attenuated by 48% and 42%, respectively). The additional energy cost of walking during 294 
the BREAKING SITTING trial was supported by carbohydrate oxidation and thus we propose that 295 
oxidation of carbohydrate may be partly responsible for the relatively lower blood glucose observed 296 
in this trial. Thus, breaking prolonged sitting is very effective at reducing postprandial glycaemia and 297 
insulinaemia.  298 
 299 
Adipose tissue responses to breaking prolonged sitting    300 
In skeletal muscle, breaking sitting with either light or moderate-intensity walking increases the 301 
expression of genes involved in glucose metabolism, including PDK4 (8). In the present study, we 302 
did not find any differences between PROLONGED SITTING and BREAKING SITTING trials in 303 
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the expression of these genes in adipose even though our walking speed, frequency and duration was 304 
very similar to that previous study (8). Thus, it appears that acutely breaking prolonged sitting with 305 
short bouts of walking reduces postprandial glycaemia/insulinaemia and leads to corresponding 306 
changes in key pathways in skeletal muscle; whereas a similar effect on postprandial 307 
glycaemia/insulinaemia is not associated with corresponding changes within adipose tissue. These 308 
divergent effects are likely to reflect the different roles of these tissues. Skeletal muscle plays a major 309 
role in the disposal of exogenously ingested glucose (especially during physical activity), whereas 310 
adipose tissue plays a relatively minor role in the acute regulation of blood glucose concentrations 311 
(28). Instead, during the postprandial period, adipose tissue plays a major role in responding to 312 
feeding and storing ingested lipids (29). Given the effect of glucose and insulin infusion on adipose 313 
tissue gene expression (10, 30), it is possible that the magnitude of postprandial glycaemia and 314 
insulinaemia in the present study was a more-than-adequate stimulus for adipose tissue, even during 315 
the BREAKING SITTING trial. We have recently shown that feeding exerts a potent effect on 316 
adipose tissue and can blunt the normal responses to prolonged structured exercise (20). Thus, we 317 
propose that the effect of feeding is likely to overcome the impact of physical activity on adipose 318 
tissue – whether this is during repeated short bouts of physical activity to break prolonged sitting or 319 
during more prolonged structured exercise.  320 
 321 
There was an apparent increase in triglyceride iAUC with BREAKING SITTING trial and this may 322 
(ostensibly) appear to be a negative response. However, this is likely explained by an enhanced lipid 323 
mobilisation in the BREAKING SITTING trial combined with technical considerations related to the 324 
assay used for the assessment of plasma triglyceride. Our method for the assessment of plasma 325 
triglyceride does not discriminate between free glycerol, bound glycerol in chylomicrons and very-326 
low-density lipoprotein; and thus it is likely that the greater triglyceride iAUC in the BREAKING 327 
SITTING trial reflects an increase in circulating free glycerol due to adipose tissue lipolysis.  328 
 329 
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Temporal changes in adipose tissue gene expression after feeding 330 
Even though we did not observe any differences in gene expression between BREAKING and 331 
PROLONGED SITTING trials, there were temporal changes in both trials that could reflect the effect 332 
of feeding per se. The expression of adipose SREBP1c was increased in both trials and this response 333 
is probably indicative of lipid synthesis after feeding (31). Moreover, there was a decrease in HSL 334 
and PDK4 in both trials, which may reflect a reduction in lipid mobilisation and oxidation. In addition, 335 
insulin receptor, IRS1 and IRS2 gene expression were consistently up-regulated and down-regulated 336 
respectively at the end of both trials. IRS-1 plays a central role as an insulin signalling receptor (32) 337 
and, similar to the present study, adipose IRS-2 mRNA expression was down-regulated in lean, 338 
overweight and obese populations after feeding (33). Taken together, the changes in SREBP1c, HSL, 339 
PDK4 and IRS-1 and IRS-2 in both trials probably reflects the normal physiological and metabolic 340 
response to feeding.  341 
 342 
We also observed an increase in adipose IL-6 and MCP-1 in both trials. Other studies have shown 343 
that adipose IL-6 and MCP-1 gene expression were up-regulated after meal consumption in lean, 344 
overweight and obese men (33), in people with metabolic syndrome (34), in people with type 2 345 
diabetes (35) and in healthy lean populations (36). A meal-induced up-regulation of adipose IL-6 and 346 
MCP-1 gene expression might support the notion that feeding induces acute transient adipose tissue 347 
inflammation. However, we cannot discount the possibility that these changes could also reflect an 348 
adipose circadian rhythm (37).  349 
 350 
Experimental Design Considerations   351 
In the present study, only two adipose biopsies were taken and therefore we do not have a complete 352 
time-course of whether the temporal changes observed in both trials was due to meal consumption 353 
and/or an entrained biological rhythm. Repeated adipose biopsies might help resolve this issue but 354 
this could be problematic due to potential confounding from local inflammation (36). We should also 355 
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emphasise that each condition (trial arm) was conducted over the course of a single day. Given the 356 
large reduction in serum insulin concentrations in the BREAKING SITTING trial and the powerful 357 
effect of insulin on adipose tissue (10, 38), it is possible that if this intervention was repeated for 358 
multiple days and/or months then this difference in postprandial insulin would lead to chronic changes 359 
in adipose in the longer term. We also do not know how the present results would compare to the 360 
same duration of exercise but performed in a different way (e.g., a single bout of 30 min or three 361 
bouts of 10 min). In the present study, we provided two mixed meals with a total ~1,725 kcal, which 362 
is more than 2-fold the energy intake in the single meal provided by Latouche et al (8). Given the 363 
extended timescale ~1,725 kcal is not an unreasonable amount of energy to consume (39), but it is 364 
possible that the physiological pressure of processing and storing this amount of energy might 365 
outweigh the impact of small bouts of physical activity in adipose tissue. Had we provided smaller 366 
meals, it is possible that physical activity could have had a moderating effect on adipose tissue-related 367 
outcomes.  368 
 369 
Conclusions 370 
Whilst breaking prolonged sitting is an effective strategy for acutely managing postprandial 371 
glycaemia and insulinaemia, this does not elicit corresponding temporal changes in adipose tissue.   372 
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Figure Legends 515 
 516 
Figure 1. Experimental protocol in PROLONGED SITTING and BREAKING SITTING trials. 517 
In the PROLONGED SITTING trial, participants sat on a chair throughout. In the BREAKING 518 
SITTING trial, participants walked on a treadmill at 6.4 km·h-1 for 2 min every 20 min. 519 
 520 
Figure 2: Blood glucose (A), insulin (C), triglyceride (E) and NEFA (G) concentrations in 521 
PROLONGED SITTING and BREAKING SITTING trials. iAUC for glucose (B), insulin (D) 522 
and triglyceride (F). iAUC is not shown for NEFA because values in both trials are mostly below 523 
baseline. The sample size is n = 10 due to difficulty in cannulating one female participant. Values are 524 
means ± SEM. # denotes significant interaction effect between PROLONGED SITTING and 525 
BREAKING SITTING trials. * denotes significantly different between prolonged sitting versus 526 
breaking sitting trials (p ≤ 0.05). The shaded box denotes meal time. Dashed lines with grey colour 527 
denotes female.  528 
 529 
Figure 3. Fold changes in relative adipose tissue gene expression under PROLONGED 530 
SITTING and BREAKING SITTING trials (all n = 9, due to lack of sufficient tissue samples for 531 
two participants). The dashed line indicates baseline. Data normalised to PPIA, internal calibrator 532 
and baseline. Samples below the detectable limit (Ct > 35) were excluded from the analysis. † denotes 533 
significant time effect and * denotes significant trial effect (p ≤ 0.05). Values are means ± SEM. 534 
 535 
Figure 4: Circulating serum IL-6 (A) leptin (C) and adiponectin (D) concentrations in 536 
PROLONGED SITTING and BREAKING SITTING trials (sample size is n = 10 due to difficulty 537 
in cannulating one participant). Adipose explant protein secretion of IL-6 (B), leptin (D) and 538 
adiponectin (F) at baseline (AM) and at end of the trial (PM) (all n = 9, due to lack of sufficient 539 
tissue samples for one male and one female participant). † denotes a significant time effect (p ≤ 540 
22 
 
0.05).Values are means ± SEM. The shaded box denotes meal time. Dashed lines with grey colour 541 
denotes female. 542 
  543 
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Table 1.  Participants physical characteristics (n = 11) 544 
Characteristics Mean ± SD 
Age (years) 50 ± 5 
Body mass (kg) 97.6 ± 20.8 
Height (m) 1.73 ± 0.08 
Waist circumference (cm) 109 ± 14 
Hip circumference (cm) 112 ± 12 
Body mass index (kg·m-2) 32.5 ± 6.7  
 Fat mass (%) 35 ± 6 
Fat mass (kg) 33.8 ± 11.0 
Fat in L1-L4 region (kg; DEXA) 4.7 ± 1.9 
Physical activity level (PAL)  1.48 ± 0.16 
Systolic blood pressure (mmHg) 137 ± 12  
Diastolic blood pressure (mmHg) 89 ± 7 
Fat mass in L1-L4 region was assessed as described previously (14). 545 
  546 
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Table 2.  Energy expenditure and substrate oxidation during each 330 min trial (n = 11) 547 
 PROLONGED 
SITTING 
BREAKING 
SITTING 
Energy expenditure (kcal) * 577 ± 129 793 ± 149 
Carbohydrate oxidation (g) * 112 ± 45  168 ± 48 
Lipid oxidation (g)  17 ± 13 18 ± 10 
Values are means ± SD. * denotes significantly different between PROLONGED SITTING versus 548 
BREAKING SITTING trials (p ≤ 0.05). 549 
 550 
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